Mr. Laetsch Brings Over 20 Years of Experience Running High-Performance Marketing Teams to Help Accelerate BioAgilytix’s Growth Through Strategic Marketing Programs
APRIL 11, 2016—Durham, NC—BioAgilytix, a leading provider of contract bioanalytical testing services with specialization in large molecule bioanalysis, has announced the addition of Martin Laetsch to its leadership team as Director of Worldwide Marketing. In this role, Mr. Laetsch will oversee the strategic planning and implementation of marketing programs to help further accelerate BioAgilytix’s business growth in the U.S., Europe, and strategic global markets. He will also be instrumental in formalizing programs to proactively gather customer feedback and insights, ensuring BioAgilytix’s services, processes, and quality remained fully aligned with customer needs and expectations.
Mr. Laetsch is a recognized thought leader in digital and performance marketing strategy, with more than 20 years of experience with prominent companies guiding product management and marketing. He was an industry pioneer in search marketing and has a record of creating high-performing marketing programs that have propelled growth for Fortune 500 companies and small businesses alike. During his most recent tenure as Director of Online Marketing at Act-On, Laetsch grew leads and revenue from inbound marketing activities to be both the fastest growing source of bookings and the single largest source of bookings in the company.
“I was drawn to BioAgilytix because of their passion for accurate, actionable data and their drive to deliver exceptional customer satisfaction,” said Mr. Laetsch. “This focus—combined with their deep expertise in large molecule bioanalysis, high quality science, and incredible people—has fostered strong growth for the company over the last several years. I look forward to joining the team and applying my expertise to help them continue on this exciting growth trajectory.”
Jim Datin, Chief Executive Officer of BioAgilytix, commented that “Martin’s experience developing and guiding strategic marketing initiatives that are focused on growth will be a great asset to the BioAgilytix team. He will also be an asset to our customer base, giving them new ways to more easily connect with our company to share their feedback in support of our continual improvement. He will help us hone our current marketing programs to drive greater results, and also take the lead on expanding those activities to Europe in support of growing our Hamburg-based subsidiary IPM Biotech, which is now BioAgilytix’s European headquarters.”
BioAgilytix is a leading bioanalytical testing laboratory specializing in large molecule bioanalysis. Located in North Carolina’s Research Triangle area, BioAgilytix provides PK, immunogenicity, biomarkers, and cell-based assay services supporting the development and release testing of biologics across a number of industries and disease states. BioAgilytix offers assay development, validation, and sample analysis under non-GLP, spirit-of-GLP, GLP, GCP, and GCLP, as well as product release testing under GMP.
BioAgilytix’s team of highly experienced scientific and QA professionals ensures high quality science, data integrity, and regulatory compliance through all phases of clinical development, and is a trusted partner to 21 of the top 25 global pharmaceutical and biotech companies. For more information, visit www.bioagilytix.com.